EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pro- vs. Anti-Inflammatory Features of Monocyte Subsets in Glioma Patients

Natalia Lehman iD, Wioleta Kowalska iD, Michał Zarobkiewicz iD, Marek Mazurek, Karolina Mrozowska, Agnieszka Bojarska-Junak iD, Radosław Rola iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24031879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Natalia Lehman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland. Hauptthemen laut MEDLINE: Monocytes, Glioma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monocytes constitute a heterogenous group of antigen-presenting cells that can be subdivided based on CD14, CD16 and SLAN expression. This division reflects the functional diversity of cells that may play different roles in a variety of pathologies including gliomas. In the current study, the three monocyte subpopulations: classical (CD14+ CD16+ SLAN−), intermediate (CD14dim CD16+ SLAN−) and non-classical (CD14low/− CD16+ SLAN+) in glioma patients’ peripheral blood were analysed with flow cytometry. The immune checkpoint molecule (PD-1, PD-L1, SIRPalpha, TIM-3) expression along with pro- and anti-inflammatory cytokines (TNF, IL-12, TGF-beta, IL-10) were assessed. The significant overproduction of anti-inflammatory cytokines by intermediate monocytes was observed. Additionally, SLAN-positive cells overexpressed IL-12 and TNF when compared to the other two groups of monocytes. In conclusion, these results show the presence of different profiles of glioma patient monocytes depending on CD14, CD16 and SLAN expression. The bifold function of monocyte subpopulations might be an additional obstacle to the effectiveness of possible immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MonocytesGliomaHumansLipopolysaccharide ReceptorsReceptors, IgGCytokinesFlow CytometryAnti-Inflammatory AgentsInterleukin-12

Stichwörter der Autor:innen

SLANcytokinesglioblastomagliomaimmune checkpointsmonocytes

Substanzen

Lipopolysaccharide ReceptorsReceptors, IgGCytokinesAnti-Inflammatory AgentsInterleukin-12

Autor:innen und Institutionen

  • Department of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland.
  • Department of Neurosurgery and Paediatric Neurosurgery, Medical University of Lublin, 20-093 Lublin, Poland.

ORCID-Profile: Natalia Lehman, Wioleta Kowalska, Michał Zarobkiewicz, Agnieszka Bojarska-Junak, Radosław Rola

Förderung

  • Medical University of Lublin

Zitieren

APA

Lehman, N., Kowalska, W., Zarobkiewicz, M., Mazurek, M., Mrozowska, K., Bojarska-Junak, A., & Rola, R. (2023). Pro- vs. Anti-Inflammatory Features of Monocyte Subsets in Glioma Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24031879

Vancouver

Lehman N, Kowalska W, Zarobkiewicz M, Mazurek M, Mrozowska K, Bojarska-Junak A, et al. Pro- vs. Anti-Inflammatory Features of Monocyte Subsets in Glioma Patients. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24031879

BibTeX
@article{Lehman2023,
  author = {Lehman, Natalia and Kowalska, Wioleta and Zarobkiewicz, Michał and Mazurek, Marek and Mrozowska, Karolina and Bojarska-Junak, Agnieszka and Rola, Radosław},
  title = {Pro- vs. Anti-Inflammatory Features of Monocyte Subsets in Glioma Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24031879}
}
Kostenlos starten →